FAK Splicing Variants Reveal New Therapeutic Vulnerability in Small Cell Lung Cancer
Small cell lung cancer (SCLC) accounts for approximately 15% of lung cancer diagnoses and remains one of oncology’s most aggressive diseases. Its rapid growth, early...
















